Breaking News:
Das geheime Potenzial von 55 $ pro Aktie in einem Clean-Energy-Deal!
Anzeige
AbCellera Biologics WKN: A2QKXS ISIN: CA00288U1066 Kürzel: ABCL Forum: Aktien Thema: Hauptdiskussion
2,600 EUR
+3,15 %+0,080
11. Nov, 14:41:08 Uhr,
Lang & Schwarz
Kommentare 1.134
valueFirst7,
24.11.2022 16:29 Uhr
0
. https://stock.vi.app/biotechnology/regeneron-and-abcellera-collaborate-on-second-antibody-program/
Halligen,
16.11.2022 16:01 Uhr
0
AbCellera Biologics - ABCL Price Target & Analyst Ratings
https://www.marketbeat.com/stocks/NASDAQ/ABCL/price-target/?RegistrationCode=SocialMedia-StockTwits&utm_source=GeneralSocialMedia&utm_medium=Social&utm_campaign=SocialMedia
Halligen,
16.11.2022 15:08 Uhr
0
Truist Securities Initiates Coverage On AbCellera Biologics with Buy Rating, Announces Price Target of $29.
Truist Securities analyst Robyn Karnauskas initiates coverage on AbCellera Biologics (NASDAQ:ABCL) with a Buy rating and announces Price Target of $29.
https://www.webullapp.com/news-detail/7660739051940864?__app_cfg__=%7B%22supportTheme%22%3Atrue%7D&sourcePage=StockNews&tickerId=950178304&disSymbol=ABCL&theme=1&color=2&hl=en&android_sdk_int=29&canary-version=&_v=1&sp=1&statusBarHeightV2=36&wbFontSetting=medium&wbFontUnit=30&wbFontSize=30&isSubsNews=false
Arras,
14.11.2022 20:53 Uhr
0
💯
Halligen,
14.11.2022 15:37 Uhr
0
https://investors.abcellera.com/news/news-releases/2022/AbCellera-Presents-New-Data-on-Further-Development-and-Characterization-of-T-Cell-Engager-Platform-at-SITC-2022/default.aspx
NILUIS,
08.11.2022 22:08 Uhr
0
https://investors.abcellera.com/news/news-releases/2022/AbCellera-Reports-Q3-2022-Business-Results/default.aspx
Halligen,
07.11.2022 15:33 Uhr
0
https://investors.abcellera.com/news/news-releases/2022/AbCellera-to-Present-at-Upcoming-Investor-Conferences-in-November/default.aspx
Halligen,
02.11.2022 17:38 Uhr
0
https://investors.abcellera.com/news/news-releases/2022/AbCelleras-First-Program-with-Regeneron-in-Multi-Target-Collaboration-Advances-in-Preclinical-Development/default.aspx
NILUIS,
28.10.2022 21:45 Uhr
0
👍🏻👌
valueFirst7,
28.10.2022 7:38 Uhr
0
https://www.globenewswire.com/news-release/2022/09/30/2525812/28124/en/Global-Monoclonal-Antibodies-mAbs-Market-Analysis-Report-2022-A-Projected-494-53-Billion-Market-by-2030.html
valueFirst7,
28.10.2022 7:36 Uhr
0
Phase II
https://www.novarockbio.com/novarock-biotherapeutics-announces-exclusive-license-agreement-with-cspc-to-develop-and-commercialize-nbl-012-in-select-international-territories/
valueFirst7,
21.10.2022 18:52 Uhr
0
https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(22)00592-8/fulltext
Arras,
12.10.2022 22:54 Uhr
0
https://www.investors.com/research/abcellera-biologics-inc-earns-rs-rating-upgrade/
Halligen,
12.10.2022 12:08 Uhr
0
https://investors.abcellera.com/news/news-releases/2022/AbCellera-to-Report-Third-Quarter-2022-Financial-Results-on-November-8-2022/default.aspx
Halligen,
06.10.2022 17:20 Uhr
0
https://investors.abcellera.com/news/news-releases/2022/AbCellera-Announces-Presentation-of-Data-from-CD3-T-Cell-Engager-Platform-at-SITC-2022/default.aspx
Mehr zu diesem Wert
|
Thema | ||
---|---|---|---|
1 | AbCellera Biologics Hauptdiskussion | ||
2 | Daytrader ABCellera📈 |
Meistdiskutiert
|
Thema | ||
---|---|---|---|
1 | EVOTEC Hauptdiskussion | +21,19 % | |
2 | MicroStrategy | +9,80 % | |
3 | TESLA MOTORS Hauptdiskussion | +7,57 % | |
4 | NEL ASA Hauptdiskussion | -6,21 % | |
5 | ALIBABA GROUP ADR Hauptdiskussion | +2,79 % | |
6 | PLUG POWER Hauptdiskussion | -0,10 % | |
7 | Canopy Hauptforum | -1,27 % | |
8 | Dax Prognose | +1,43 % | |
9 | Renk Group | +2,39 % | |
10 | New World Solutions Bitcoin | +5,69 % | Alle Diskussionen |
Aktien
|
Thema | ||
---|---|---|---|
1 | EVOTEC Hauptdiskussion | +21,76 % | |
2 | MicroStrategy | +9,72 % | |
3 | TESLA MOTORS Hauptdiskussion | +7,19 % | |
4 | NEL ASA Hauptdiskussion | -4,84 % | |
5 | ALIBABA GROUP ADR Hauptdiskussion | +2,85 % | |
6 | PLUG POWER Hauptdiskussion | -0,10 % | |
7 | Canopy Hauptforum | -1,27 % | |
8 | Renk Group | +2,39 % | |
9 | New World Solutions Bitcoin | +5,69 % | |
10 | DPCM Capital Hauptdiskussion | +8,95 % | Alle Diskussionen |